Citations

Clear

4847 citation(s) found for "Yu, Eric".

Sentinel Epileptiform Discharges Activating Two Seizure Networks on Intracranial EEG
Lapalme-Remis, Samuel, Payne, Eric T., Brinkmann, Benjamin H., Britton, Jeffrey W., Brinkmann, Benjamin H. , Brinkmann, Benjamin H , Lapalme-Remis, Samuel, Payne, Eric T., Britton, Jeffrey W.

Mayo Clinic

Journal of Clinical Neurophysiology | November 14, 2021 | Volume: 39 | Issue: 3 | Pages: e10-e14

10.1097/wnp.0000000000000872 | PMID 35255009 Get It

Summary: Sentinel epileptiform discharges (SEDs) are epileptiform transients preceding the onset of a focal seizure seen on scalp EEG. Despite their potential localizing value, formal study of SED has been limited. The authors report a patient with MRI-negative focal-onset epilepsy whose seizures on scalp and intracranial EEG were always preceded by SED. Although the location and morphology of the SED was invariable, the seizures after the discharge were of two clearly distinct types, each with different semiology and region of spread on intracranial EEG. This suggests that the SED played a role in activating two distinct seizure networks. A right temporal lobectomy with amygdalohippocampectomy was performed. The resection included both the region of the SED as well as the seizure-onset zone of the more common seizure type, achieving seizure freedom at 3 years after surgery. Further research exploring whether the localization of SED is a reliable indicator of the seizure-onset zone could aid surgical planning in patients whose seizures are preceded by SED.
Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease
Ghosh, Auyon , Hobbs, Brian D. , Moll, M, Saferali, Aabida , Boueiz, Adel , Yun, Jeong H. , Sciurba, Frank, Barwick, Lucas, Flaherty, Kevin, Criner, G J, Brown, Kevin K. , Martinez, Fernando J., Lomas, D M, DeMeo, DL, Silverman, E K, Sciurba, Frank C. , Hoffman, Eric A. , Comellas, Alejandro P. , Lomas, David A. , Rossiter, Harry B. , Ghosh, Auyon J , Wise, Robert , Cho, Michael H , Hersh, Craig P , Yun, Jeong H , Hoffman, Eric A , Comellas, Alejandro P , Hobbs, Brian D , Boueiz, Adel , Limper, Andrew H. , Criner, Gerard J. , Wise, Robert A. , Castaldi, Peter J. , Carey, Vincent J. , Cho, Michael H. , Hersh, Craig P.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | November 11, 2021 | Volume: 205 | Issue: 3 | Pages: 313-323

10.1164/rccm.202106-1404oc | PMID 34762809 Get It

Abstract Rationale Multiple studies have demonstrated an increased risk of chronic obstructive pulmonary disease (COPD) in heterozygous carriers of the AAT (alpha-1 antitrypsin) Z allele. However, it is not known if MZ subjects with COPD are phenotypically different from noncarriers (MM genotype) with COPD. Objectives To assess if MZ subjects with COPD have different clinical features compared with MM subjects with COPD. Methods Genotypes of SERPINA1were ascertained by using whole-genome sequencing data in three independent studies. We compared outcomes between MM subjects with COPD and MZ subjects with COPD in each study and combined the results in a meta-analysis. We performed longitudinal and survival analyses to compare outcomes in MM and MZ subjects with COPD over time. Measurements and Main Results We included 290 MZ subjects with COPD and 6,184 MM subjects with COPD across the three studies. MZ subjects had a lower FEV1% predicted and greater quantitative emphysema on chest computed tomography scans compared with MM subjects. In a meta-analysis, the FEV1was 3.9% lower (95% confidence interval [CI], −6.55% to −1.26%) and emphysema (the percentage of lung attenuation areas <−950 HU) was 4.14% greater (95% CI, 1.44% to 6.84%) in MZ subjects. We found one gene, PGF(placental growth factor), to be differentially expressed in lung tissue from one study between MZ subjects and MM subjects. Conclusions Carriers of the AAT Z allele (those who were MZ heterozygous) with COPD had lower lung function and more emphysema than MM subjects with COPD. Taken with the subtle differences in gene expression between the two groups, our findings suggest that MZ subjects represent an endotype of COPD.
491 BASECAMP-1: an observational study to identify relapsed solid tumor patients with human leukocyte antigen (HLA) loss of heterozygosity (LOH) and leukapheresis for future CAR T-cell therapy
Molina, Julian R. , Go, William Y., Patel, Sandip Pravin , Liechty, Kirstin B., Fan-Port, Michelle, Perera, Jason, Mardiros, Armen, Beutner, Karl R., Lozac’hmeur, Ariane, Ng, Eric Wai-Choi , Maloney, David G. , Hecht, J. Randolph, Kopetz, Scott , Simeone, Diane M. , Lin, Yi

Mayo Clinic

Regular and Young Investigator Award Abstracts | November 9, 2021 | Volume: No volume available | Issue: No issue available | Pages: A522-A522

10.1136/jitc-2021-sitc2021.491 Get It

482 Phase1/2 study of an anti-galectin-9 antibody, LYT-200, in patients with metastatic solid tumors
Filipović, Aleksandra, Wainber, Zev, Bendell, Johanna C. , Jankú, Filip , Bolen, Joseph B., Elenko, Eric, Korth, C, Dranitsaris, George , Wang, Judy , Sharma, Manish R. , Mahipal, Amit , Korth, Christopher

Mayo Clinic

Regular and Young Investigator Award Abstracts | November 9, 2021 | Volume: No volume available | Issue: No issue available | Pages: A512-A512

10.1136/jitc-2021-sitc2021.482 Get It

Pharmacogenomics Testing in Patients with Liver Transplant and Potential Impact on Prospective Management
Wright, Jessica , Moyer, Ann M. , Sutton, Joseph , Chaney, Amanda , Nicholson, Wayne T. , Melik, Razan M. El , Matey, Eric T. , Mara, Kristin C. , Black, John L. , Wright, Jessica A , Chaney, Amanda J , El Melik, Razan M, Bielinski, Suzette , Mara, Kristin C , Black, John Logan, Caraballo, Pedro J , El Melik, Razan M , Bielinski, Suzette J. , Caraballo, Pedro J.

Mayo Clinic

Pharmacogenomics | November 8, 2021 | Volume: 22 | Issue: 18 | Pages: 1177-1183

10.2217/pgs-2021-0076 | PMID 34747639 Get It

Evolving concepts in the perioperative management of obstructive sleep apnea after endoscopic skull base surgery
Rabinowitz, Mindy, Chaskes, Mark B., Thorp, Brian D. , Toskala, Elina , Nyquist, Gurston , Evans, James J., Choby, Garret , Wang, Eric W , Choby, Garret , Rosen, Marc R

Mayo Clinic

International Forum of Allergy & Rhinology | November 8, 2021 | Volume: 12 | Issue: 1 | Pages: 5-10

10.1002/alr.22905 | PMID 34747119 Get It

Protocol for pragmatic randomised trial: integrating electronic health record-based behavioural economic ‘nudges’ into the electronic health record to reduce preoperative testing for patients undergoing cataract surgery
Ahmadi, Alast , Sorensen, Andrea, Villaflores, Chad , Mafi, John N. , Vangala, Sitaram S., Hofer, Ira , Bartlett, John , Cheng, Eric, Duval, Victor, Elashoff, David , Goldstein, Noah J. , Moore, James M. , Pessegueiro, Antonio M. , Skootsky, Samuel A. , Turner, Ashley, Bartlett, John D , Ladapo, Joseph A , Damberg, Cheryl L. , Ladapo, Joseph A. , Shu, Suzanne B. , Sarkisian, Catherine A.

Mayo Clinic

BMJ Open | November 3, 2021 | Volume: 11 | Issue: 11 | Pages: e049568

10.1136/bmjopen-2021-049568 | PMID 34732478 Get It

Introduction Robust randomised trial data have shown that routine preoperative (pre-op) testing for cataract surgery patients is inappropriate. While guidelines have discouraged testing since 2002, cataract pre-op testing rates have remained unchanged since the 1990s. Given the challenges of reducing low-value care despite strong consensus around the evidence, innovative approaches are needed to promote high-value care. This trial evaluates the impact of an interdisciplinary electronic health record (EHR) intervention that is informed by behavioural economic theory. Methods and analysis This pragmatic randomised trial is being conducted at UCLA Health between June 2021 and June 2022 with a 12-month follow-up period. We are randomising all UCLA Health physicians who perform pre-op visits during the study period to one of the three nudge arms or usual care. These three nudge alerts address (1) patient harm, (2) increased out-of-pocket costs for patients and (3) psychological harm to the patients related to pre-op testing. The nudges are triggered when a physician starts to order a pre-op test. We hypothesise that receipt of a nudge will be associated with reduced pre-op testing. The primary outcome will be the change in the percentage of patients undergoing pre-op testing at 12 months. Secondary outcomes will include the percentage of patients undergoing specific categories of pre-op tests (labs, EKGs, chest X-rays (CXRs)), the efficacy of each nudge, same-day surgery cancellations and cost savings. Ethics and dissemination The study protocol was approved by the institutional review board of the University of California, Los Angeles as well as a nominated Data Safety Monitoring Board. If successful, we will have created a tool that can be disseminated rapidly to EHR vendors across the nation to reduce inappropriate testing for the most common low-risk surgical procedures in the country. Trial registration number ClinicalTrials.gov identifier: NCT04104256 .
Incorporating Robustness to Imaging Physics into Radiomic Feature Selection for Breast Cancer Risk Estimation
Acciavatti, Raymond J. , Cohen, Eric A. , Gastounioti, Aimilia , Pantalone, Lauren , Vachon, Celine M. , Gastounioti, Aimilia , Vachon, Celine, Acciavatti, Raymond J , Maghsoudi, Omid Haji , Hsieh, Meng-Kang, Conant, Emily F. , Scott, Christopher G. , Winham, Stacey J. , Kerlikowske, Karla , Vachon, Celine M. , Maidment, Andrew D. A. , Kontos, Despina

Mayo Clinic

Cancers | November 1, 2021 | Volume: 13 | Issue: 21 | Pages: 5497

10.3390/cancers13215497 | PMID 34771660 Get It

Digital mammography has seen an explosion in the number of radiomic features used for risk-assessment modeling. However, having more features is not necessarily beneficial, as some features may be overly sensitive to imaging physics (contrast, noise, and image sharpness). To measure the effects of imaging physics, we analyzed the feature variation across imaging acquisition settings (kV, mAs) using an anthropomorphic phantom. We also analyzed the intra-woman variation (IWV), a measure of how much a feature varies between breasts with similar parenchymal patterns—a woman’s left and right breasts. From 341 features, we identified “robust” features that minimized the effects of imaging physics and IWV. We also investigated whether robust features offered better case-control classification in an independent data set of 575 images, all with an overall BI-RADS® assessment of 1 (negative) or 2 (benign); 115 images (cases) were of women who developed cancer at least one year after that screening image, matched to 460 controls. We modeled cancer occurrence via logistic regression, using cross-validated area under the receiver-operating-characteristic curve (AUC) to measure model performance. Models using features from the most-robust quartile of features yielded an AUC = 0.59, versus 0.54 for the least-robust, with p < 0.005 for the difference among the quartiles.
Ribonuclease recruitment using a small molecule reduced c9ALS/FTD r(G 4 C 2 ) repeat expansion in vitro and in vivo ALS models
Bush, Jessica A. , Aikawa, Haruo , Fuerst, Rita, Li, Yue , Ursu, Andrei , Meyer, Samantha M. , Benhamou, Raphael I. , Chen, Jonathan L. , Khan, Tanya , Wagner-Griffin, Sarah , Meter, Montina J. Van , Tong, Yuquan , Olafson, Hailey, McKee, Kendra , Childs‐Disney, Jessica L. , Zhang, Yong‐Jie , Wang, Eric T. , Wang, Kye Won , Petrucelli, Leonard , Van Meter, Montina J , McKee, Kendra K , Gendron, Tania F , Zhang, Yong-Jie , Coyne, Alyssa N , Wang, Eric T , Wang, Kye Won , Petrucelli, Leonard , Rothstein, Jeffrey D , Disney, Matthew D , Benhamou, Raphael I , Aikawa, Haruo , Gendron, Tania F. , Coyne, Alyssa N. , Yildirim, Ilyas , Rothstein, Jeffrey D. , Disney, Matthew D.

Mayo Clinic

Science Translational Medicine | October 27, 2021 | Volume: 13 | Issue: 617 | Pages: No page available

10.1126/scitranslmed.abd5991 | PMID 34705518 Get It

Small-molecule recruitment of an endogenous nuclease rescues pathologies associated with c9ALS/FTD in vivo by targeting an RNA repeat expansion.
Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformation
You, Xiaona , Liu, Fabao , Binder, Moritz , Vedder, Alexis , Lasho, Terra, Wen, Zhi , Flietner, Evan, Rajagopalan, Adhithi , Zhou, Yun , Finke, Christy M. , Mangaonkar, Abhishek A. , Liao, Ruiqi , Kong, Guangyao , Ranheim, Erik A. , Droin, Nathalie , Balasis, Maria E. , Levine, Ross L. , Will, Britta , Nadiminti, Kalyan , Yang, David T. , Xu, Wei , Padron, Eric , Patnaik, Mrinal M. , Zhang, Jing , Kong, Guangyao , Droin, Nathalie , Nikolaev, Sergey , Balasis, Maria , Will, Britta , Yang, David , Solary, Eric , Xu, Wei , Patnaik, Mrinal , Zhang, Jing , Binder, Moritz , Gao, Xin , Hunter, Anthony M. , Abdel‐Wahab, Omar , Geissler, Klaus H. , Solary, Éric

Mayo Clinic

Blood | October 26, 2021 | Volume: 139 | Issue: 7 | Pages: 1066-1079

10.1182/blood.2021012519 | PMID 34699595 Get It

Abstract Mutations in chromatin regulator ASXL1 are frequently identified in myeloid malignancies, in particular ∼40% of patients with chronic myelomonocytic leukemia (CMML). ASXL1 mutations are associated with poor prognosis in CMML and significantly co-occur with NRAS mutations. Here, we show that concurrent ASXL1 and NRAS mutations defined a population of CMML patients who had shorter leukemia-free survival than those with ASXL1 mutation only. Corroborating this human data, Asxl1−/− accelerated CMML progression and promoted CMML transformation to acute myeloid leukemia (AML) in NrasG12D/+ mice. NrasG12D/+;Asxl1−/− (NA) leukemia cells displayed hyperactivation of MEK/ERK signaling, increased global levels of H3K27ac, upregulation of Flt3. Moreover, we find that NA-AML cells overexpressed all the major inhibitory immune checkpoint ligands: programmed death-ligand 1 (PD-L1)/PD-L2, CD155, and CD80/CD86. Among them, overexpression of PD-L1 and CD86 correlated with upregulation of AP-1 transcription factors (TFs) in NA-AML cells. An AP-1 inhibitor or short hairpin RNAs against AP-1 TF Jun decreased PD-L1 and CD86 expression in NA-AML cells. Once NA-AML cells were transplanted into syngeneic recipients, NA-derived T cells were not detectable. Host-derived wild-type T cells overexpressed programmed cell death protein 1 (PD-1) and T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT) receptors, leading to a predominant exhausted T-cell phenotype. Combined inhibition of MEK and BET resulted in downregulation of Flt3 and AP-1 expression, partial restoration of the immune microenvironment, enhancement of CD8 T-cell cytotoxicity, and prolonged survival in NA-AML mice. Our study suggests that combined targeted therapy and immunotherapy may be beneficial for treating secondary AML with concurrent ASXL1 and NRAS mutations.